Kariman Chaba
Impact in
- Immunology top 2%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune cells in cancer
- interferon and immune responses
- T-cell and B-cell Immunology
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Immunology 12
- Immune Cell Function and Interaction 9
- Immunotherapy and Immune Responses 5
- Oncology 11
- Cancer Immunotherapy and Biomarkers 5
- CAR-T cell therapy research 2
- Chemokine receptors and signaling 2
- Co-authors
- Guido Kroemer (11 shared papers)laurence ZITVOGEL (7 shared papers)Laura Senovilla (8 shared papers)David Pierre Enot (5 shared papers)Sylvain Ladoire (4 shared papers)Vichnou Poirier-Colame (4 shared papers)Suzette Delaloge (3 shared papers)Fabrice André (3 shared papers)
- Journals
- OncoImmunology (4 papers)Autophagy (3 papers)Oncotarget (2 papers)Cell Cycle (2 papers)Cancer Research (2 papers)
- Partner nations
- FranceUnited StatesSweden
In The Last Decade
Kariman Chaba
24 papers receiving 3.0k citations
Kariman Chaba's Hit Papers
Peers
Comparison fields: 5 of 98
- Immunology 1.5k
- Oncology 1.3k
- Gastroenterology 92
- Cancer Research 235
- Physiology 75
Countries citing papers authored by Kariman Chaba
This map shows the geographic impact of Kariman Chaba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kariman Chaba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kariman Chaba more than expected).
Fields of papers citing papers by Kariman Chaba
This network shows the impact of papers produced by Kariman Chaba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kariman Chaba. The network helps show where Kariman Chaba may publish in the future.
Co-authors
The 25 scholars most cited alongside Kariman Chaba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy Hit paper breakdown → | 2014 | 888 |
| 2 | 2015 | 390 | |
| 3 | 2011 | 291 | |
| 4 | 2013 | 258 | |
| 5 | 2015 | 145 | |
| 6 | 2012 | 116 | |
| 7 | 2013 | 108 | |
| 8 | 2016 | 100 | |
| 9 | 2015 | 92 | |
| 10 | 2021 | 87 | |
| 11 | 2014 | 67 | |
| 12 | 2012 | 65 | |
| 13 | 2019 | 59 | |
| 14 | 2014 | 55 | |
| 15 | 2015 | 53 | |
| 16 | 2016 | 52 | |
| 17 | 2016 | 47 | |
| 18 | 2013 | 37 | |
| 19 | 2013 | 36 | |
| 20 | 2018 | 18 |
About Kariman Chaba
Kariman Chaba is a scholar working on Immunology, Oncology, Gastroenterology, Biotechnology and Epidemiology, having authored 24 papers that have together received 3.0k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (9 papers), Cancer Immunotherapy and Biomarkers (5 papers), Immunotherapy and Immune Responses (5 papers), Cancer Research and Treatments (3 papers), Autophagy in Disease and Therapy (3 papers), Gastrointestinal Tumor Research and Treatment (3 papers), CAR-T cell therapy research (2 papers) and Chemokine receptors and signaling (2 papers). The work is most often cited by research in Immunology (1.5k citations), Oncology (1.3k citations), Gastroenterology (92 citations), Cancer Research (235 citations) and Physiology (75 citations). Kariman Chaba has collaborated with scholars based in France, United States and Sweden. Frequent co-authors include Guido Kroemer, laurence ZITVOGEL, Laura Senovilla, David Pierre Enot, Sylvain Ladoire, Vichnou Poirier-Colame, Suzette Delaloge, Fabrice André, Michaëla Semeraro and Oliver Kepp. Their work appears in journals such as OncoImmunology, Autophagy, Oncotarget, Cell Cycle and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.